This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

The Oxford Science Park Innovation Award returns as Oxfordshire Business Awards resume

The Oxford Science Park Innovation Award returns as Oxfordshire Business Awards resume

03 Dec 2021

The Oxford Science Park Innovation Award returns as Oxfordshire Business Awards resume Apply now to join previous winners – Oxford Space Systems, Perspectum Diagnostics, Adaptix & Oxford Biomedica Oxford, UK, December 3 2021 – Oxfordshire companies which are progressing valuable innovations can apply now for The Oxford Science Park Innovation Award, one of 2022’s Oxfordshire Business Awards (OXBA). The Oxford Science Park, one of the UK’s... Read more

The Oxford Science Park and Occupiers Gather to Celebrate Success

The Oxford Science Park and Occupiers Gather to Celebrate Success

29 Nov 2021

The Oxford Science Park and its occupiers gathered together recently to celebrate successes and progress over recent months – a period in which the importance of science and technology companies in keeping the population healthy became clearer than ever. Companies from across the Park, including LRE System, Oxford Endovascular, Oxford Vacmedix, OXGENE, Oxsonics Therapeutics, Physiomics, ProImmune and Sitryx, chatted to attendees from Advanced... Read more

Sitryx appoints Tanya E. Borsuk, Ph.D., as Chief Business Officer

Sitryx appoints Tanya E. Borsuk, Ph.D., as Chief Business Officer

10 Nov 2021

Oxford, UK – 10 November 2021 – Sitryx (“the Company”), a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-inflammation and immuno-oncology, today announces the appointment of Tanya E. Borsuk, Ph.D., as its Chief Business Officer. Tanya brings 15 years of strategic and scientific expertise across business development and corporate strategy. At Sitryx, Tanya will join the... Read more

OMass Unveils Rich Drug Discovery Pipeline

OMass Unveils Rich Drug Discovery Pipeline

04 Nov 2021

OMass Unveils Rich Drug Discovery Pipeline Targeting Intractable or Inadequately Drugged Membrane and Complex-bound Proteins Oxford, United Kingdom – 4 November 2021 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems, today unveiled its pipeline of five novel, differentiated small molecule drug programs, targeting intractable or inadequately drugged... Read more

Acquisition of ATDBio by Biotage AB to provide platform for further growth

Acquisition of ATDBio by Biotage AB to provide platform for further growth

20 Oct 2021

Acquisition of ATDBio by Biotage AB to provide platform for further growth Founders look forward to continued focus on customers and innovation Oxford and Southampton, UK, October 20 2021 – ATDBio, a leader in complex oligonucleotide synthesis, is pleased to announce that it has been acquired by the Swedish life sciences company Biotage AB1 for approximately £45m in cash and shares. The acquisition, which provides Biotage with expertise in... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More